Michael Kishbauch

2013

In 2013, Michael Kishbauch earned a total compensation of $376.5K as Director, Former President and Chief Executive Officer Retired at Achillion Pharmaceuticals, a 87% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$96,759
Salary$271,876
Other$7,911
Total$376,546

Kishbauch received $271.9K in salary, accounting for 72% of the total pay in 2013.

Kishbauch also received $96.8K in non-equity incentive plan and $7.9K in other compensation.

Rankings

In 2013, Michael Kishbauch's compensation ranked 10,229th out of 12,286 executives tracked by ExecPay. In other words, Kishbauch earned more than 16.7% of executives.

ClassificationRankingPercentile
All
10,229
out of 12,286
17th
Division
Manufacturing
3,804
out of 4,612
18th
Major group
Chemicals And Allied Products
1,209
out of 1,462
17th
Industry group
Drugs
949
out of 1,156
18th
Industry
Pharmaceutical Preparations
740
out of 890
17th
Source: SEC filing on April 18, 2014.

Kishbauch's colleagues

We found five more compensation records of executives who worked with Michael Kishbauch at Achillion Pharmaceuticals in 2013.

2013

Milind Deshpande

Achillion Pharmaceuticals

Chief Executive Officer

2013

David Apelian

Achillion Pharmaceuticals

Chief Medical Officer

2013

Mary Fenton

Achillion Pharmaceuticals

Chief Financial Officer

2013

Joseph Truitt

Achillion Pharmaceuticals

Executive Vice President and Chief Commercial Officer

2013

Gautam Shah

Achillion Pharmaceuticals

Former Executive Vice President and Chief Compliance Officer

You may also like